In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Graybug Vision Inc.

www.graybug.com

Latest From Graybug Vision Inc.

Allergan Improves Safety Of Abicipar, But Not Enough Compared To Lucentis, Eylea

Allergan has been developing abicipar to provide less-frequent dosing in neovascular AMD, but despite success in reducing intraocular inflammation with a new formulation, the injectable still doesn’t match the safety of entrenched competitors.

Clinical Trials Commercial

Execs On The Move, February 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Venture Funding Deals, June 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced April through May 2016.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, September 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • GrayBug Inc.
  • GrayBug LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Graybug Vision Inc.
  • Senior Management
  • Jeffrey Cleland, PhD, Pres. & CEO
    Ming Yang, PhD, Dir. Rsch.
    Charles Semba, MD, CMO
    Ward Peterson, PhD, SVP, Preclinical Dev.
  • Contact Info
  • Graybug Vision Inc.
    Phone: (646) 285-6057
    303 Twin Dolphin Dr., Ste. 600
    Redwood City, CA 94065
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register